The traditional pharmaceutical model may be ineffective for treating brain diseases once they onset due to the blood-brain barrier, necessitating a shift towards engineering-based solutions.

“the traditional pharmace iical model to care for these diseases may not work once there's onset of disease because of the bloodb brain barrier and the concept there is that you know drugs which go into the body don't get through effectively the barrier between the blood and the Brain to be able to treat brain diseases we need new forms of innovation and this is where I think you will see the prominence of engineering based Solutions rather than drug Discovery based Solutions grow materially to help with these diseases”